top of page
Search Results

357 items found for "Interferon regulatory factor 1"

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/ - 15 | Biologics 2024 March 13 - 15 | 9th German Pharm-Tox Summit March 23 - 24, 2024 | Ligand Recognition Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, June 26 to July 2, 2023

    If you want to present a poster, all you have to do is fill out the submission form and submit a 1-minute Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ Internal and external modulation factors of the orexin system (REVIEW). GPCR Events, Meetings, and Webinars NEW ERNEST ECI Zoominar (July 6, 2023) 19th World Congress of Basic ONCORNET2.0 Final Symposium (August 31 - September 1, 2023) Registration ends Tomorrow!

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    New Course Dates: Principles of Pharmacology I :  October 3, 10, 17, 24 (four sessions) Principles of Pharmacology II :  October 31, November 7, 14, 21, December 5 (five sessions) Courses Highlights Act GPCR Event Spotlight    11th Adhesion GPCR Workshop    Location:  Mexico City Dates:  October 23-25, to ‘improve on existing GLP-1 drugs’ Opening Ceremony of Xuzhou Zhongshu Research Site and CNS Drug Adhesion GPCR Workshop November 5 - 7, 2024 | 16th Annual PEGS Europe   July 12 - 17, 2026 | 20th World

  • 📰 GPCR Weekly News, April 15 to 21, 2024

    am to 12 pm EDT. through multiple G protein families Rapid elucidation of agonist-driven regulation of the neurokinin 1 – May 1, 2024 | FREE ASPET Virtual Award Lecture Series May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS Europe 2024 Conference and Exhibition Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, September 4 to 10, 2023

    GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video Now, explore the Classified GPCR News from September 4th to 10th, 2023. Insights into GPCR Function Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Once-Daily Oral Paltusotine Achieved The Primary And All Secondary Endpoints In The Phase 3 Pathfndr-1 , 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET

  • All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024

    Cell and Platelet Transcriptomes , and we want to wish her the best of luck on her talk today at the 11th November 14th: The Application of GPCR Ligand Kinetics to Candidate Design. *Lessons are every Thursday at 10 AM EST. check for Longboard, seeing blockbuster potential in epilepsy med Call for GPCR Papers Deadline: Nov 1, | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress of Basic and

  • 📰 GPCR Weekly News, June 19 to 25, 2023

    Please note that you will have to submit a 1-minute abstract video. Let's review the weekly Classified GPCR News from June 19th to June 25th, 2023. Inversago Pharma Presents Data from Phase 1b Trial of INV-202, a Peripheral CB1r Blocker for Metabolic Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress ONCORNET2.0 Final Symposium (August 31 - September 1, 2023) Registration ends Tomorrow!

  • 📰 GPCR Weekly News, May 6 to 12, 2024

    GPCR Podcast Episode #151 is out! A special episode with our board, meet Drs. Did you watch Episode #150 of the Dr. GPCR Podcast? of Latrophilin-1 Adhesion GPCR Nanoclusters in Inhibitory Synapses Embryonic spatiotemporal expression Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults Crinetics - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    Registrations open on December 15th and close on February 1st to both Dr. Neurocrine Biosciences Confirms its Plans to Evaluate Two New Muscarinic Agonist Candidates in Phase 1 Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 5 - 10, 2024 | AACR Annual Meeting April 22 - 23, 2024 | Endocrine Metabolic GPCRs May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS Europe 2024

  • Signaling pathways activated by sea bass gonadotropin-inhibitory hormone peptides in COS-7 cells...

    indicate that sea bass GnIHR signals can be transduced through the PKA and PKC pathways, and GnIH can interfere teleosts, and represent a starting point for the study of interactions with multiple neuroendocrine factors

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    glutamate receptor 5 (mGluR5), can lead to sustained calcium signaling and activation of transcription factors Another challenge is the potential interference of tagging molecules with GPCR function. G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 Nature communications, 8(1), 443. https://doi.org/10.1038/s41467-017-00357-2 Jong, Y. Neurochemical research, 42(1), 166172. https://doi.org/10.1007/s11064-016-2026-6 Mendizabal-Zubiaga,

  • 📰 GPCR Weekly News, January 16 to 22, 2023

    Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling The cannabinoid receptor 1 antagonist AM6545 stimulates the Akt-mTOR axis and in vivo muscle protein Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1). SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (June 10 - 11, 2023).

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    Check the weekly Classified GPCR News from July 10th to July 16th, 2023. GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates Industry News Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted That Matters" GPCR Events, Meetings, and Webinars ONCORNET2.0 Final Symposium (August 31 - September 1, NEW MPGPCR Conference (November 15 -17, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion

  • Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids

    This suggests differences in the regulatory function of PI(4,5)P2 between class A and class B GPCRs."

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    Submit a 1-minute abstract video and tell us more about your project in this form. Don't forget to check out the weekly Classified GPCR News from July 17th to July 23rd, 2023. ONCORNET2.0 Final Symposium (August 31 - September 1, 2023) Registration ends Tomorrow! MPGPCR Conference (November 15 -17, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    omics applications, which can be analyzed by an established AI framework which involves three stages: 1) AI is providing a dramatic acceleration of the drug discovery process at multiple stages: 1. However, there are also certain cons associated with the use of AI in this field: 1) the quality and The future According to the authors, the future of AI relies in 6 main areas: 1. Regulatory challenges, ethical considerations, and the need for interpretability of AI-driven models

  • Helix 8 in chemotactic receptors of the complement system

    Complement factor C5a exerts its effect through the activation of C5aR1, chemotactic receptor 1, and

  • 📰 GPCR Weekly News, June 17 to 23, 2024

    The classes will be online Thursdays from 10 am EST. Submit your entries by August 15th, 2024. Let’s dive into the Classified GPCR News from June 17th to 23rd, 2024. M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • Comparative study of neuropeptide signaling systems in Hemiptera

    Their expression profiles at the probe and feeding stages reflected potential regulatory roles in probe

  • 📰 GPCR Weekly News, May 13 to 19, 2024

    We've got 15 insightful GPCR research papers and updates from the industry. Episode 152 with Dr. Let’s dive into the Classified GPCR News from May 13th to 19th, 2024. prospective ligand discovery Industry News Roche reports positive Phase Ib results for its dual GLP-1/ Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, March 11 to 17, 2024

    We have 10 GPCR papers, five industry news, and one job ad. Let’s dive into the Classified GPCR News from March 11th to 17th, 2024 Adhesion GPCRs ADGRG1, an adhesion Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, August 21 to 27, 2023

    Register by September 6, 12 pm EST. September 22: Don't miss the Dr. Share your project with a 1-minute abstract video using this form. Reproducibility of Tanso Biosciences' GPCR Assay GPCR Events, Meetings, and Webinars August 31 - September 1, , 2024 | AACR Annual Meeting NEW May 13 - 17, 2024 | 20th Annual PEGS Boston Summit NEW May 16 - 19, Writer Postdoctoral Fellow Research Laboratory Specialist Associate Postdoc Research Associate Director, Regulatory

  • The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?

    A series of evidence shows that TGR5 induces protein kinase B (AKT), nuclear factor kappa-B (NF-κB), (RhoA), exchange protein activated by cAMP (Epac), and transient receptor potential ankyrin subtype 1

  • Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...

    Dihydroxycholesterol Induces Behavioral Hypersensitivity through Mitogen-Activated Protein Kinase and Nuclear Factor These effects are blocked by the selective small molecule GPR183 antagonist, SAE-14. hypersensitivity implicate potential contributions of mitogen-activated protein kinase (MAPK) and nuclear factor activation of MAPKs (extracellular signal-regulated kinase [ERK], p38) and redox-sensitive transcription factors SAE-14 blocked these effects and behavioral hypersensitivity.

  • 📰 GPCR Weekly News, February 12 to 18, 2024

    GPCR Members get 10% off with code MPDRGPCR10. Let’s dive into the Classified GPCR News from February 12th to 18th, 2024 GPCR Activation and Signaling March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 1 - 4, 2024 | 19th Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29 Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026

  • 📰 GPCR Weekly News, February 6 to 12, 2023

    Addex Therapeutics Ltd Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1 SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (March 14-17, 2023). SLAS 2023 B Building Biology in 3D Symposium. (June 10 - 11, 2023). (June 11 - 16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023.

  • Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...

    hypertension and proteinuria, with a worldwide incidence of 3–8% and high maternal mortality, is a risk factor Obesity, immunological diseases and endocrine metabolic diseases are high-risk factors for the development The notion that placenta is the core factor in the pathogenesis of preeclampsia is still prevailing.

  • 📰 GPCR Weekly News - January 9 to 15, 2023

    Proof-of-Concept Trial Evaluating S1PR Mechanism of Action and Target Engagement Novo Nordisk's GLP-1 SLAS2023 International Conference and Exhibition (February 25 - March 1). (March 14-17, 2023). 8th and final ERNEST Meeting in Crete. (May 3-7, 2023). (June 10 -11, 2023). (June 11-16, 2023). 19th World Congress of Basic & Clinical Pharmacology 2023. (July 2 - 7).

bottom of page